Tevogen Bio Holdings (TVGN) Return on Equity (2023 - 2026)

Tevogen Bio Holdings has reported Return on Equity for 4 years, with the latest figure at 0.02% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity fell 2.0% year-over-year to 0.02%; the trailing twelve-month figure through Mar 2026 stood at 0.02% (down 2.0% YoY), and the FY2025 full-year result was 0.04%, up 2.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.02%, down from 0.03% in the prior quarter.
• The five-year high for Return on Equity was 0.08% in Q4 2024, with the low at 0.0% in Q1 2023.
• Historically, Return on Equity has averaged 0.03% across 4 years, with a median of 0.03% in 2025.
• Annual changes were most pronounced in 2024 — Return on Equity increased 8 bps — and 2025, when it slipped 5 bps.
• Tevogen Bio Holdings' Return on Equity stood at 0.0% in 2023, then soared by 7838 bps to 0.08% in 2024, then tumbled by 61 bps to 0.03% in 2025, then retreated by 28 bps to 0.02% in 2026.
• The last three Return on Equity figures came in at 0.02% (Q1 2026), 0.03% (Q4 2025), and 0.04% (Q3 2025), per Business Quant data.